Monday, July 15, 2013

Pfizer's Next Move.......After RA...its Oncology and Metabolic disorders.............

Pfizer has always been the company which intrigued me in many ways......the company which acted as a massive shark for quite long is being quite mum for a while....In Jan there was a buzz that the company is splitting its business in the similar ground to Abbott but there were no initiation activity from the company end. And then there aggressive movement in the Metabolic and immunology segment (Many of the compounds in Phase I/II) we still need need to check the company strategy going forward.....After its nutrition business sales it has cash in hand....will it go for Onyx deal to expand its portfolio in Oncology, as recently it collaborated for Cytomax for its ADC technology.........Will Oncology be the next game changer for Pfizer growth the way it has been for Roche?????.....Will it be able to displace Roche products in some oncology segments the way it’s trying hard to displace Humira in RA with its expected block buster product???????

Many things to watch from Pfizer's end!


No comments:

Post a Comment